Grants and Contributions:
Title:
ARP - Accelerating Commercialization and Product Capabilities
Agreement Number:
1006937
Agreement Value:
$75,000.00
Agreement Date:
Jun 5, 2023 - Jul 12, 2024
Description:
This project aims to enhance the company's commercial capabilities and maintain product innovation to ensure competitiveness and achieve corporate goals.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Montreal, Quebec, CA H3A 2G4
Reference Number:
172-2023-2024-Q1-1006937
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
702633710
Recipient Type:
For-profit organization
Recipient's Legal Name:
Gray Oncology Solutions Inc.
Federal Riding Name:
Ville-Marie--Le Sud-Ouest--Île-des-Soeurs
Federal Riding Number:
24077
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
511211